MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation Operating Cash Flow 2011-2026 | NVTA
Annual Operating Cash Flow Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -493 M | -560 M | -299 M | -145 M | -92.2 M | -98 M | -76.3 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -76.3 M | -560 M | -252 M |
Quarterly Operating Cash Flow Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -34.4 M | - | -411 M | -282 M | -148 M | - | -384 M | -219 M | -89.5 M | - | -185 M | -123 M | -62.4 M | - | -97.8 M | -61.1 M | -28.4 M | - | -76.7 M | -58.7 M | -32.9 M | - | -66.7 M | -41.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -28.4 M | -411 M | -133 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.12 | -0.88 % | $ 1.42 M |  USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 24.41 | 1.2 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 27.63 | -4.06 % | $ 297 M |  China |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 105.79 | 0.61 % | $ 4.17 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
Danaher Corporation
DHR
|
6.42 B | $ 209.19 | - | $ 149 B | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 11.26 | - | $ 319 M | Israel |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 23.09 | 0.35 % | $ 698 M | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | - | - | $ 79.8 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 209.54 | - | $ 23.3 B | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 29.94 | 3.46 % | $ 832 M | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 19.25 | 2.45 % | $ 1.03 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
1.44 B | $ 73.09 | -0.23 % | $ 28.5 B | USA |
 |
Interpace Biosciences
IDXG
|
4.65 M | $ 1.74 | -5.95 % | $ 7.63 M | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | $ 103.45 | 0.06 % | $ 19.5 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 287.13 | 0.64 % | $ 23.9 B | USA |
 |
Guardant Health
GH
|
-185 M | $ 95.4 | 1.04 % | $ 12 B | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
738 M | $ 166.06 | - | $ 8.23 B | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.43 | 1.14 % | $ 410 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 104.09 | -0.54 % | $ 8.59 B |  Irlanda |
 |
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 3.86 | 2.93 % | $ 2.07 M | USA |
 |
IDEXX Laboratories
IDXX
|
1.18 B | $ 649.23 | 4.19 % | $ 52.2 B | USA |
 |
Illumina
ILMN
|
837 M | $ 122.9 | 1.96 % | $ 19.5 B | USA |
 |
Natera
NTRA
|
-432 M | $ 209.53 | 0.09 % | $ 20.6 B | USA |
 |
IQVIA Holdings
IQV
|
2.65 B | $ 164.88 | - | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 379.66 | - | $ 28.4 B |  Schweiz |
|
Biodesix
BDSX
|
-48.6 M | $ 13.02 | 1.96 % | $ 1.69 B | USA |
 |
Pacific Biosciences of California
PACB
|
-259 M | $ 1.66 | 5.06 % | $ 421 M | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 73.61 | 0.26 % | $ 5.09 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.1 | - | $ 4.82 M | USA |